Dynamics of Disease Progression and Gastrostomy Tube Placement in Children and Adolescents with Cystic Fibrosis: Application of Joint Models for Longitudinal and Time-to-Event Data.

BACKGROUND Previous small-sample studies have examined the effect of gastrostomy (g-) tube placement on weight, height, and lung function in adolescent patients with cystic fibrosis (CF), but there are no RCTs to date reporting efficacy. The goal of this study was to implement a dynamic prediction model to 1) understand the role of rapid lung function decline in g-tube placement in real-world clinical settings; 2) provide a prognostic tool with the potential to aid clinicians in optimizing the timing of g-tube placement, in relation to rate of lung function decline and current nutrition status. METHODS A dynamic prediction model was developed, utilizing data on patients 6-21 years of age from the Cystic Fibrosis Foundation Patient Registry (1997-2013). A joint model was implemented, which coupled a semiparametric mixed model to characterize rapid lung function decline with a time-to-event model to identify risk factors for g-tube initiation. RESULTS The 4,034 individuals (21.3%) who underwent g-tube placement during adolescence or young adulthood had poorer nutrition and lung function at baseline and initially had increased rates of pancreatic enzyme use, infection and gastroesophageal reflux disease, compared to those who did not receive g-tubes; these associations changed over follow up. Rapid lung function decline was associated with increased risk of g-tube supplementation. CONCLUSIONS By jointly modeling longitudinal patterns of lung function decline with g-tube delivery, it is possible to construct prognostic aids to evaluate treatment delivery in relation to the onset of rapid lung function decline and other important clinical markers. These algorithms have the potential to enable more effective monitoring of disease progression and promote more timely treatment delivery.

[1]  H. Quinton,et al.  Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. , 2008, Journal of the American Dietetic Association.

[2]  Mark D Schluchter,et al.  Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients , 2002, Statistics in medicine.

[3]  M. Seid,et al.  Inhaled tobramycin effectively reduces FEV1 decline in cystic fibrosis. An instrumental variables analysis. , 2013, Annals of the American Thoracic Society.

[4]  Zhumin Zhang,et al.  Comparison of the use of body mass index percentiles and percentage of ideal body weight to screen for malnutrition in children with cystic fibrosis. , 2004, The American journal of clinical nutrition.

[5]  Joseph G Ibrahim,et al.  Basic concepts and methods for joint models of longitudinal and survival data. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  David Wypij,et al.  Pulmonary function between 6 and 18 years of age , 1993, Pediatric pulmonology.

[7]  A. Jawad,et al.  Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. , 2000, The Journal of pediatrics.

[8]  T. Liou,et al.  Predictive 5-year survivorship model of cystic fibrosis. , 2001, American journal of epidemiology.

[9]  Dynamic prediction of outcome for patients with severe aortic stenosis: application of joint models for longitudinal and time-to-event data , 2015, BMC Cardiovascular Disorders.

[10]  Raouf S Amin,et al.  A semiparametric approach to estimate rapid lung function decline in cystic fibrosis. , 2013, Annals of epidemiology.

[11]  A. Morton,et al.  Enteral tube feeding for cystic fibrosis (Review) , 2012 .

[12]  M. Schechter Patient registry analyses: seize the data, but caveat lector. , 2008, The Journal of pediatrics.

[13]  Charles A. Johnson,et al.  Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. , 2007, The Journal of pediatrics.

[14]  Yongseok Park,et al.  Real‐Time Individual Predictions of Prostate Cancer Recurrence Using Joint Models , 2013, Biometrics.

[15]  C. Goss,et al.  Tackling the increasing complexity of CF care , 2015, Pediatric pulmonology.

[16]  Annalisa V Piccorelli,et al.  Jointly modeling the relationship between longitudinal and survival data subject to left truncation with applications to cystic fibrosis. , 2012, Statistics in medicine.

[17]  M. Corey,et al.  A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. , 1988, Journal of clinical epidemiology.

[18]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[19]  Scott Sagel,et al.  A comparison of change point models with application to longitudinal lung function measurements in children with cystic fibrosis , 2016, Statistics in medicine.

[20]  Keith R. Abrams,et al.  Joint modelling of longitudinal and survival data: incorporating delayed entry and an assessment of model misspecification , 2015, Statistics in medicine.